Japanese Society of Nephrology

JSN/ERA-EDTA Joint Symposium was held in London (May, 30, 2015, 17:00-18:30) and Nagoya (June, 6, 2015, 9:45-11:15) under the Committee on International Relations and Global Liaison Committee, and was successfully finished without any trouble. (Please see the following information.) We are deeply grateful for Dr. Matsuo, Dr. Ito, and Dr. Nangaku, and the related participants and staffs for their kind cooperation. It was a first time that both societies joined the symposium with each other. We hope that the relationship between the JSN and ERA-EDTA will further deepen in future. ● ERA-RDTA&JSN Joint Symposium; May 30, 2015, 17:00-18:30 London
Chair: Dr. Sadayoshi Ito、Dr. Andrzej Wiecek
Dr. Seiichi Matsuo: Past, present, future: continuous challenge against kidney disease Dr. Masaomi Nangaku: Development of novel drugs targeting CKD: hypoxia, oxidative stress, and epigenetics
Dr. Kai-Uwe Eckardt: Treatment practice in patients with CKD: results from the GCKD study
Dr. Alberto Ortiz: CKJ-translational research

● JSN/ERA-EDTA Joint Symposium: June 6, 2015, 9:45-11:15 Nagoya
Chair: Dr. Motoko Yanagita、Dr. Ziad A Massy
Dr. Seiichi Matsuo: JSN's Challenge against Kidney Disease and Collaboration between JSN and ERA-EDTA
Dr. Masaomi Nangaku: Hypoxia as a new therapeutic target in CKD
Dr. Andrzej Wiecek: Adipose tissue cytokines and cardiovascular complications in CKD patients. Where are we now?
Dr. Peter Stenvinkel: Renal Biomimicry-could it provide hope to patients with kidney disease?